Table 1. Subject characteristics.
| Characteristic | Control | Cirrhosis | p-values |
|---|---|---|---|
| Patients, n | 42 | 46 (14 with HCC) | |
| Age in years, median (range) | 62 (34–81) | 58.5 (35–79) | 0.61 |
| Male/female sex | 21/21 | 29/17 | |
| Height median, cm (range) | 170 (157–191) | 173 (150–197) | 0.67 |
| Weight median, kg (range) | 76 (51–149) | 85 (48–165) | 0.03 |
| BMI median, kg/m2 (range) | 25.5 (18.9–46.0) | 29.7 (18.0–43.4) | 0.01 |
| Child-Pugh class A/B/C/na* | – | 30/12/1/3 | |
| MELD median (range) | – | 8 (7–19) | |
| UKELD median (range) | – | 48.1 (44.7–60.5) | |
| Total bilirubin median, µmol/L (range) | – | 17 (7–86) | |
| Serum albumin median, g/L (range) | – | 35 (24–45) | |
| INR median, % (range) | – | 1.07 (0.82–1.78) | |
| ALT median, IU/L (range) | – | 27 (14–105) | |
| ALP median, IU/L (range) | – | 100 (40–440) | |
| Creatinine, µmol/L | – | 67 (38–147) | |
| Sodium, mM | – | 139 (126–144) |
*Some blood metrics were not available for three patients. HCC, hepatocellular carcinoma; BMI, body mass index; MELD, model of end-stage liver disease; UKELD, the United Kingdom model for end-stage liver disease; INR, international normalized ratio; ALT, alanine aminotransferase; ALP, alkaline phosphatase.